205 related articles for article (PubMed ID: 29903572)
1. Emerging roles of atypical chemokine receptor 3 (ACKR3) in normal development and physiology.
Quinn KE; Mackie DI; Caron KM
Cytokine; 2018 Sep; 109():17-23. PubMed ID: 29903572
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR3.
Zarca AM; Adlere I; Viciano CP; Arimont-Segura M; Meyrath M; Simon IA; Bebelman JP; Laan D; Custers HGJ; Janssen E; Versteegh KL; Buzink MCML; Nesheva DN; Bosma R; de Esch IJP; Vischer HF; Wijtmans M; Szpakowska M; Chevigné A; Hoffmann C; de Graaf C; Zarzycka BA; Windhorst AD; Smit MJ; Leurs R
Mol Pharmacol; 2024 Mar; 105(4):301-312. PubMed ID: 38346795
[TBL] [Abstract][Full Text] [Related]
3. ACKR3 promotes CXCL12/CXCR4-mediated cell-to-cell-induced lymphoma migration through LTB4 production.
Antonello P; Pizzagalli DU; Foglierini M; Melgrati S; Radice E; Thelen S; Thelen M
Front Immunol; 2022; 13():1067885. PubMed ID: 36713377
[TBL] [Abstract][Full Text] [Related]
4. Disruption of placental ACKR3 impairs growth and hematopoietic development of offspring.
Fukuoka A; Wilson GJ; Pitmon E; Koumbas Foley L; Johnsson H; Pingen M; Graham GJ
Development; 2024 Feb; 151(4):. PubMed ID: 38300826
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of the atypical chemokine receptor 3 (ACKR3) by a small-molecule agonist attenuates fibrosis in a preclinical liver but not lung injury model.
Van Loy T; De Jonghe S; Castermans K; Dheedene W; Stoop R; Verschuren L; Versele M; Chaltin P; Luttun A; Schols D
Cell Mol Life Sci; 2022 May; 79(6):293. PubMed ID: 35562519
[TBL] [Abstract][Full Text] [Related]
6. Bilayer lipids modulate ligand binding to atypical chemokine receptor 3.
Eberle SA; Gustavsson M
Structure; 2024 May; ():. PubMed ID: 38776922
[TBL] [Abstract][Full Text] [Related]
7. Atypical chemokine receptor 3 induces colorectal tumorigenesis in mice by promoting β-arrestin-NOLC1-fibrillarin-dependent rRNA biogenesis.
Yang J; Miao RR; Li YN; Pan T; Wu SH; Qu XJ; Cui SX
Acta Pharmacol Sin; 2022 Nov; 43(11):2967-2976. PubMed ID: 35365782
[TBL] [Abstract][Full Text] [Related]
8. Ackr3-Venus knock-in mouse lights up brain vasculature.
Ehrlich AT; Semache M; Couvineau P; Wojcik S; Kobayashi H; Thelen M; Gross F; Hogue M; Le Gouill C; Darcq E; Bouvier M; Kieffer BL
Mol Brain; 2021 Sep; 14(1):151. PubMed ID: 34583741
[TBL] [Abstract][Full Text] [Related]
9. Atlas of the anatomical localization of atypical chemokine receptors in healthy mice.
Melgrati S; Radice E; Ameti R; Hub E; Thelen S; Pelczar P; Jarrossay D; Rot A; Thelen M
PLoS Biol; 2023 May; 21(5):e3002111. PubMed ID: 37159457
[TBL] [Abstract][Full Text] [Related]
10. Adaptation and Constraint in the Atypical Chemokine Receptor Family in Mammals.
Pan L; Lv J; Zhang Z; Zhang Y
Biomed Res Int; 2018; 2018():9065181. PubMed ID: 30345310
[TBL] [Abstract][Full Text] [Related]
11. Atypical chemokine receptors: emerging therapeutic targets in cancer.
Torphy RJ; Yee EJ; Schulick RD; Zhu Y
Trends Pharmacol Sci; 2022 Dec; 43(12):1085-1097. PubMed ID: 36307250
[TBL] [Abstract][Full Text] [Related]
12. Atypical chemokine receptors in cancer.
Samus M; Rot A
Cytokine; 2024 Apr; 176():156504. PubMed ID: 38266462
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for selectivity and antagonism in extracellular GPCR-nanobodies.
Schlimgen RR; Peterson FC; Heukers R; Smit MJ; McCorvy JD; Volkman BF
Nat Commun; 2024 May; 15(1):4611. PubMed ID: 38816420
[TBL] [Abstract][Full Text] [Related]
14. Large chemokine binding spectrum of human and mouse atypical chemokine receptor GPR182 (ACKR5).
Bonnavion R; Liu S; Kawase H; Roquid KA; Offermanns S
Front Pharmacol; 2023; 14():1297596. PubMed ID: 38026988
[TBL] [Abstract][Full Text] [Related]
15. ACKR3 in olfactory glia cells shapes the immune defense of the olfactory mucosa.
Dietz A; Senf K; Neuhaus EM
Glia; 2024 Jun; 72(6):1183-1200. PubMed ID: 38477581
[TBL] [Abstract][Full Text] [Related]
16. Atypical chemokine receptors in the immune system.
Comerford I; McColl SR
Nat Rev Immunol; 2024 May; ():. PubMed ID: 38714818
[TBL] [Abstract][Full Text] [Related]
17. Atypical chemokine receptor CCRL2 is overexpressed in prostate cancer cells.
Reyes N; Benedetti I; Rebollo J; Correa O; Geliebter J
J Biomed Res; 2017 Nov; 33(1):17-23. PubMed ID: 29497024
[TBL] [Abstract][Full Text] [Related]
18. Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3).
Dekkers S; Comez D; Karsai N; Arimont-Segura M; Canals M; Caspar B; de Graaf C; Kilpatrick LE; Leurs R; Kellam B; Hill SJ; Briddon SJ; Stocks MJ
ACS Med Chem Lett; 2024 Jan; 15(1):143-148. PubMed ID: 38229752
[TBL] [Abstract][Full Text] [Related]
19. Editorial: Emerging receptors as new targets in health and disease.
Dam J; Hanson J; Szpakowska M
Front Endocrinol (Lausanne); 2022; 13():1073794. PubMed ID: 36465643
[No Abstract] [Full Text] [Related]
20. CXCR7 Targeting and Its Major Disease Relevance.
Wang C; Chen W; Shen J
Front Pharmacol; 2018; 9():641. PubMed ID: 29977203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
